Cargando…
Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials
BACKGROUND: Trials investigating the role of mesenchymal stem cells (MSCs) in increasing ejection fraction (LVEF) after acute myocardial infarction (AMI) have raised some controversies. This study was conducted to find whether transplantation of MSCs after AMI can help improve myocardial performance...
Autores principales: | Attar, Armin, Bahmanzadegan Jahromi, Fateme, Kavousi, Shahin, Monabati, Ahmad, Kazemi, Asma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650261/ https://www.ncbi.nlm.nih.gov/pubmed/34876213 http://dx.doi.org/10.1186/s13287-021-02667-1 |
Ejemplares similares
-
Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trials
por: Hosseinpour, Alireza, et al.
Publicado: (2022) -
Major cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials
por: Attar, Armin, et al.
Publicado: (2022) -
Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)
por: Attar, Armin, et al.
Publicado: (2022) -
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial
por: Attar, Armin, et al.
Publicado: (2023) -
Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial
por: Attar, Armin, et al.
Publicado: (2022)